366 related articles for article (PubMed ID: 27070462)
41. Developmental pathways hijacked by osteosarcoma.
Mortus JR; Zhang Y; Hughes DP
Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
[TBL] [Abstract][Full Text] [Related]
42. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
[TBL] [Abstract][Full Text] [Related]
43. CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.
Tang Q; Lu J; Zou C; Shao Y; Chen Y; Narala S; Fang H; Xu H; Wang J; Shen J; Khokha R
Oncogene; 2018 Jul; 37(27):3617-3630. PubMed ID: 29610525
[TBL] [Abstract][Full Text] [Related]
44. Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP).
Liao J; McCauley LK
Cancer Metastasis Rev; 2006 Dec; 25(4):559-71. PubMed ID: 17165129
[TBL] [Abstract][Full Text] [Related]
45. p53-dependent and p53-independent anticancer activity of a new indole derivative in human osteosarcoma cells.
Cappadone C; Stefanelli C; Malucelli E; Zini M; Onofrillo C; Locatelli A; Rambaldi M; Sargenti A; Merolle L; Farruggia G; Graziadio A; Montanaro L; Iotti S
Biochem Biophys Res Commun; 2015 Nov; 467(2):348-53. PubMed ID: 26433123
[TBL] [Abstract][Full Text] [Related]
46. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.
Zhang S; Wang Y; Chen S; Li J
Biomed Pharmacother; 2018 Oct; 106():1396-1403. PubMed ID: 30119212
[TBL] [Abstract][Full Text] [Related]
47. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
48. The p27 Pathway Modulates the Regulation of Skeletal Growth and Osteoblastic Bone Formation by Parathyroid Hormone-Related Peptide.
Zhu M; Zhang J; Dong Z; Zhang Y; Wang R; Karaplis A; Goltzman D; Miao D
J Bone Miner Res; 2015 Nov; 30(11):1969-79. PubMed ID: 25917430
[TBL] [Abstract][Full Text] [Related]
49. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
Haydon RC; Luu HH; He TC
Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
[TBL] [Abstract][Full Text] [Related]
50. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
51. RECQ DNA helicases and osteosarcoma.
Lu L; Jin W; Liu H; Wang LL
Adv Exp Med Biol; 2014; 804():129-45. PubMed ID: 24924172
[TBL] [Abstract][Full Text] [Related]
52. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of microRNA-210 inhibits osteosarcoma growth in vitro and in vivo.
Liu C; Tang X
Mol Med Rep; 2015 Sep; 12(3):3674-3680. PubMed ID: 26044868
[TBL] [Abstract][Full Text] [Related]
54. Tumor-suppressing effects of miR451 in human osteosarcoma.
Xu H; Mei Q; Shi L; Lu J; Zhao J; Fu Q
Cell Biochem Biophys; 2014 May; 69(1):163-8. PubMed ID: 24218283
[TBL] [Abstract][Full Text] [Related]
55. Oncogenic roles of serine-threonine kinase receptor-associated protein (STRAP) in osteosarcoma.
Pruksakorn D; Klangjorhor J; Lirdprapamongkol K; Teeyakasem P; Sungngam P; Chaiyawat P; Phanphaisarn A; Settakorn J; Srisomsap C
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1039-1047. PubMed ID: 30276452
[TBL] [Abstract][Full Text] [Related]
56. Long noncoding RNA AFAP1‑AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR‑4695‑5p/TCF4‑β‑catenin signaling.
Li R; Liu S; Li Y; Tang Q; Xie Y; Zhai R
Mol Med Rep; 2018 Aug; 18(2):1616-1622. PubMed ID: 29901121
[TBL] [Abstract][Full Text] [Related]
57. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
Tenta R; Sourla A; Lembessis P; Koutsilieris M
Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
[TBL] [Abstract][Full Text] [Related]
58. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
59. Second messenger signaling of c-fos gene induction by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: its role in osteoblast proliferation and osteoclast-like cell formation.
Kano J; Sugimoto T; Kanatani M; Kuroki Y; Tsukamoto T; Fukase M; Chihara K
J Cell Physiol; 1994 Nov; 161(2):358-66. PubMed ID: 7962120
[TBL] [Abstract][Full Text] [Related]
60. Murine models of osteosarcoma: A piece of the translational puzzle.
Walia MK; Castillo-Tandazo W; Mutsaers AJ; Martin TJ; Walkley CR
J Cell Biochem; 2018 Jun; 119(6):4241-4250. PubMed ID: 29236321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
